CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+11.05%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$3.61B
AUM Growth
+$3.61B
(+41%)
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
45.45%
Top 10 Holdings %
Top 10 Hldgs %
69.27%
Holding
743
New
91
Increased
185
Reduced
188
Closed
147
Top Buys
| 1 |
NVIDIA
NVDA
|
$625M |
| 2 |
Meta Platforms (Facebook)
META
|
$245M |
| 3 |
Apple
AAPL
|
$235M |
| 4 |
Advanced Micro Devices
AMD
|
$151M |
| 5 |
Amazon
AMZN
|
$129M |
Top Sells
| 1 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
$27.1M |
| 2 |
Avidity Biosciences
RNA
|
$20.4M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$14.9M |
| 4 |
Protagonist Therapeutics
PTGX
|
$13M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$12.2M |
Sector Composition
| 1 | Technology | 33.37% |
| 2 | Financials | 18.76% |
| 3 | Healthcare | 17.59% |
| 4 | Communication Services | 13.93% |
| 5 | Consumer Discretionary | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.24T
| $717M | 19.72% | 5,805,368 +5,058,156 | +677% | +$625M |
|
|
2
Meta Platforms (Facebook)
META
$1.86T
| $390M | 10.73% | 773,655 +486,023 | +169% | +$245M |
|
3
Coinbase
COIN
$78.2B
| $331M | 9.1% | 1,488,975 -52,929 | -3% | -$11.8M |
|
|
4
Apple
AAPL
$3.45T
| $283M | 7.79% | 1,344,487 +1,114,519 | +485% | +$235M |
|
|
5
Avidity Biosciences
RNA
$5.99B
| $210M | 5.76% | 5,129,103 -500,000 | -9% | -$20.4M |
|
|
6
Advanced Micro Devices
AMD
$264B
| $157M | 4.31% | 967,231 +933,783 | +2,792% | +$151M |
|
|
7
Amazon
AMZN
$2.44T
| $131M | 3.61% | 679,086 +667,289 | +5,656% | +$129M |
|
8
PTC Therapeutics
PTCT
$3.92B
| $115M | 3.16% | 3,756,469 +30,843 | +0.8% | +$943K |
|
9
Alphabet (Google) Class C
GOOG
$2.58T
| $91.7M | 2.52% | +500,000 | New | +$91.7M |
|
10
Nike
NKE
$114B
| $76M | 2.09% | +1,007,841 | New | +$76M |
|
11
Tarsus Pharmaceuticals
TARS
$2.47B
| $59.7M | 1.64% | 2,197,385 +74,855 | +4% | +$2.03M |
|
12
Tesla
TSLA
$1.08T
| $47.4M | 1.3% | +239,384 | New | +$47.4M |
|
13
Stoke Therapeutics
STOK
$1.08B
| $45.5M | 1.25% | 3,365,744 | – | – |
|
14
Establishment Labs
ESTA
$1.2B
| $42.7M | 1.17% | 939,948 | – | – |
|
|
15
Protagonist Therapeutics
PTGX
$3.67B
| $41M | 1.13% | 1,182,268 -375,368 | -24% | -$13M |
|
16
Alibaba
BABA
$322B
| $37.8M | 1.04% | 524,626 +135,083 | +35% | +$9.73M |
|
17
Sumitomo Mitsui Financial
SMFG
$105B
| $37.6M | 1.03% | 2,800,730 | – | – |
|
|
AACT
18
Ares Acquisition Corporation II
AACT
$706M
| $35.3M | 0.97% | 3,308,231 +3,000,331 | +974% | +$32M |
|
19
UroGen Pharma
URGN
$900M
| $35.2M | 0.97% | 2,099,482 +472,893 | +29% | +$7.94M |
|
20
Papa John's
PZZA
$1.6B
| $32.7M | 0.9% | +696,800 | New | +$32.7M |
|
21
Energy Transfer Partners
ET
$60.8B
| $29.6M | 0.81% | 1,827,000 +50,000 | +3% | +$811K |
|
22
Mercer International
MERC
$223M
| $28.2M | 0.77% | 3,300,000 | – | – |
|
23
Rocket Pharmaceuticals
RCKT
$354M
| $23.7M | 0.65% | 1,100,000 | – | – |
|
24
Microsoft
MSFT
$3.77T
| $20.8M | 0.57% | 46,617 +41,639 | +836% | +$18.6M |
|
|
ANSC
25
Agriculture & Natural Solutions Acquisition Corp
ANSC
$471M
| $20.2M | 0.56% | 1,973,679 +637,748 | +48% | +$6.53M |
|